Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib + TACE in hepatocellular carcinoma
NCT01164202Phase 3Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jul 2010
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sunitinib in hepatocellular carcinoma (HCC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Jul 2010; status: completed.
02
Drugs
sunitinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01164202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01164202.